NCT01413568 - Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions

Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial RemissionChronic Lymphocytic Leukemia (CLL)Multiple Myeloma (MM)Myelodysplastic Syndrome (MDS)Myeloproliferative Disorders

Interventions

DRUG

POL6326

PROCEDURE

Leukapheresis

PROCEDURE

PBSC Transplant

Trial Locations (2)

63110

Washington University School of Medicine, St Louis

66205

University of Kansas Cancer Center, Kansas City